Boston Sci Could Resume ICD Sales Within 30 Days

By Susan Kelly, Reuters

Boston Scientific Corp. (BSX.N) could be selling implantable heart rhythm devices again within 30 days if no new issues arise beyond the paperwork problems revealed this week.

"Our number one conclusion is ... that Boston likely overreacted in pulling its products from the market and has a good chance of getting this resolved in the next week or two with the outside risk being 30 days," JPMorgan analyst Michael Weinstein wrote in a note to clients.

Boston Scientific spokesman Paul Donovan declined to provide details on when the company might resume selling the devices but said, "We are working closely with the FDA to resolve the situation as soon as possible."

Complete Story >> http://www.reuters.com/article/idUSN1717104020100317